Eli Lilly and Company

Science into healing for chronic disease

Indianapolis, Indiana, United States

Eli Lilly and Company is a global healthcare leader specializing in the discovery, development, manufacturing, and marketing of innovative pharmaceutical products. Headquartered in Indianapolis, Indiana, it focuses on addressing unmet medical needs across various therapeutic areas.

Shareable draft

Check out Eli Lilly and Company on @MedStartr Today Eli Lilly and Company is a global healthcare leader specializing in the discovery, development, manufacturing, and marketing of innovative pharmaceutical products. Headquartered in Indianapolis, Indiana, it focuses on addressing unmet medical needs across various therapeutic areas. #COVID19 #Diabetes #Immunology #Neurodegeneration #Pain #CardiometabolicHealth #MentalBehavioralHealth #CancerOncology #DrugDiscoveryDevelopment #MedMo #MedStartrVentures

https://www.medstartr.ai/s/rxzvfOl0hcY

Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.

Get Involved in Eli Lilly and Company

How We Help

Core Technology

drug discovery systems, foundation models for biology and chemistry, manufacturing AI

Key Differentiators

Continuous, heavy investment in R&D, therapeutic specialization in high-growth areas (e.g., diabetes, oncology), significant expansion of manufacturing capacity, strong intellectual property and patent portfolio, strategic collaborations, and integration of AI across operations.

Clinical Focus

COVID-19 treatment

Target Customers

Healthcare providers, hospitals, pharmacies, and indirectly, patients. Also veterinarians/farmers for animal health products.

Product Stage

Mature

Company Info

Business Model: B2B/B2C Pharmaceutical; revenue generated through product sales, collaboration and licensing agreements, and animal health product sales.
Founded: 1876
Website: lilly.com

Disease Areas

COVID-19 Diabetes Immunology Neurodegeneration Pain Cardiometabolic Health Mental Health Cancer & Oncology

Technologies

NVIDIA BioNeMoVera Rubin ArchitecturePharmaceutical InnovationR&DAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

FDA approved: Mounjaro (diabetes/obesity), Zepbound (obesity), Kisunla (early Alzheimer's), Omvoh (IBD). Phase 3 trials completed: tirzepatide 22.5% weight loss (SURMOUNT-1), donanemab 35% decline slowdown (TRAILBLAZER-2), orforglipron pending April 2026 PDUFA. Published in NEJM. Real-world evidence programs: TROPHIES, EMPRISE

🛡️

IP Protection

Strong intellectual property and patent portfolio.

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Eli Lilly and Company?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.